Latest Stem cell Stories

World Stem Cells, LLC facilitates Stem Cell Therapies at a state of the art clinic in beautiful Cancun. The clinic is staffed by top specialist in the field of stem cell implants and a new laboratory to support the stem cell treatments given. Lutz, Florida (PRWEB) February 05, 2013 World Stem Cells, LLC. contract laboratory and clinic World Stem Cells Clinic a new adult stem cell laboratory being built in Cancun, Mexico to support Stem Cell research, stem cell clinical trials and stem...

Epidermal growth factor has been found to speed the recovery of blood-making stem cells after exposure to radiation, according to Duke Medicine researchers. The finding could open new options for treating cancer patients and victims of dirty bombs or nuclear disasters. Reported in the Feb. 3, 2013, issue of the journal Nature Medicine, the researchers explored what had first appeared to be an anomaly among certain genetically modified mice with an abundance of epidermal growth factor in...

SHELBY TOWNSHIP, Mich., Feb. 1, 2013 /PRNewswire/ -- Shelby Township doctor diagnosis woman with rare poorly-understood condition. (Photo: http://photos.prnewswire.com/prnh/20130201/DE52888 ) Emma, a 35-year-old Detroit woman spent years unable to look in the mirror because the left half of her face had sunken over time. She had already consulted with several doctors who said they couldn't help when she found Brett Kotlus, M.D., a cosmetic and oculofacial plastic surgeon in Shelby...

New research has shown the presence of a disease affecting small blood vessels, known as microangiopathy, in the bone marrow of diabetic patients. While it is well known that microangiopathy is the cause of renal damage, blindness and heart attacks in patients with diabetes, this is the first time that a reduction of the smallest blood vessels has been shown in bone marrow, the tissue contained inside the bones and the main source of stem cells. These precious cells not only replace old...

CLEVELAND, Jan. 31, 2013 /PRNewswire/ -- Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan(®) System technology in the treatment of thermal burn wounds. The FDA Investigational Device Exemption (IDE-15140) allows Arteriocyte and its clinical partners to initiate evaluation of autologous platelet gel (APG)...

SAN DIEGO, Jan. 31, 2013 /PRNewswire/ -- ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell-derived cell therapy, announced today that the Company was granted 20 patents worldwide in 2012, eight U.S. and twelve foreign. These patents bolster the Company's already strong proprietary position for its ground-breaking diabetes product, VC-01, as well as other applications of its broad...

Stem cells from bone marrow or fat improve recovery after stroke in rats, finds a study published in BioMed Central's open access journal Stem Cell Research & Therapy. Treatment with stem cells improved the amount of brain and nerve repair and the ability of the animals to complete behavioral tasks. Stem cell therapy holds promise for patients but there are many questions which need to be answered, regarding treatment protocols and which cell types to use. This research attempts to...

A new study from Boston University School of Medicine (BUSM) shows that tissues derived from induced pluripotent stem (iPS) cells in an experimental model were not rejected when transplanted back into genetically identical recipients. The study, published online in Cell Stem Cell, demonstrates the potential of utilizing iPS cells to develop cell types that could offer treatment for a wide range of conditions, including diabetes, liver and lung diseases, without the barrier of immune...

NEW YORK, Jan. 28, 2013 /PRNewswire/ -- In what is one of the most significant developments in the company's history, Americord Registry, a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking, has added the esteemed and highly influential Dr. Richard Waldman, M.D. to its medical advisory board. Dr. Waldman, a highly respected obstetrician and former President of the American College of Obstetricians and Gynecologists (ACOG), is the highest...

CLEVELAND, Jan. 28, 2013 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease announced today that Paul Resnick, M.D., M.B.A., has joined the company as Vice President of Business Development. Dr. Resnick brings more than 25 years of healthcare and business development experience to the role. In this position, Dr. Resnick's efforts will be to drive business...